In the originally published version of this article [Ali OH, Bomze D, Risch L, et al. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2020. https://doi.org/10.1093/cid/ciaa1496], there was an error in Figure 2. The fourth column chart title currently reads “Cardiolipin IgM” but should have read “Cardiolipin IgG”. The article has been updated to reflect this change, and the publisher regrets this error.
. 2021 Sep 22;73(9):1746. doi: 10.1093/cid/ciab532
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Omar Hasan Ali
1,2,3, David Bomze
3,4, Lorenz Risch
5,6, Silvio D Brugger
7, Matthias Paprotny
8, Myriam Weber
8, Sarah Thiel
8, Lukas Kern
9, Werner C Albrich
10, Philipp Kohler
10, Christian R Kahlert
10,11, Pietro Vernazza
10, Philipp K Bühler
12, Reto A Schüpbach
12, Alejandro Gómez-Mejia
7, Alexandra M Popa
13, Andreas Bergthaler
13, Josef M Penninger
1,14, Lukas Flatz
2,3,15,16,✉
Omar Hasan Ali
1
Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
2
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
3
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Find articles by Omar Hasan Ali
David Bomze
3
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
4
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Find articles by David Bomze
Lorenz Risch
5
Labormedizinisches Zentrum Dr. Risch, Vaduz, Liechtenstein
6
Center of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Bern, Switzerland
Find articles by Lorenz Risch
Silvio D Brugger
7
Department of Infectious Diseases and Hospital Hygiene, University Hospital Zurich, Zurich, Switzerland
Find articles by Silvio D Brugger
Matthias Paprotny
8
Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
Find articles by Matthias Paprotny
Myriam Weber
8
Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
Find articles by Myriam Weber
Sarah Thiel
8
Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
Find articles by Sarah Thiel
Lukas Kern
9
Department of Pulmonology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Find articles by Lukas Kern
Werner C Albrich
10
Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Find articles by Werner C Albrich
Philipp Kohler
10
Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Find articles by Philipp Kohler
Christian R Kahlert
10
Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
11
Department of Infectious Diseases and Hospital Epidemiology, Children’s Hospital of Eastern Switzerland, St. Gallen, Switzerland
Find articles by Christian R Kahlert
Pietro Vernazza
10
Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Find articles by Pietro Vernazza
Philipp K Bühler
12
Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland
Find articles by Philipp K Bühler
Reto A Schüpbach
12
Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland
Find articles by Reto A Schüpbach
Alejandro Gómez-Mejia
7
Department of Infectious Diseases and Hospital Hygiene, University Hospital Zurich, Zurich, Switzerland
Find articles by Alejandro Gómez-Mejia
Alexandra M Popa
13
Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Find articles by Alexandra M Popa
Andreas Bergthaler
13
Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Find articles by Andreas Bergthaler
Josef M Penninger
1
Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
14
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
Find articles by Josef M Penninger
Lukas Flatz
2
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
3
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
15
Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
16
Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Find articles by Lukas Flatz
1
Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
2
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
3
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
4
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
5
Labormedizinisches Zentrum Dr. Risch, Vaduz, Liechtenstein
6
Center of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Bern, Switzerland
7
Department of Infectious Diseases and Hospital Hygiene, University Hospital Zurich, Zurich, Switzerland
8
Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
9
Department of Pulmonology, Kantonsspital St. Gallen, St. Gallen, Switzerland
10
Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
11
Department of Infectious Diseases and Hospital Epidemiology, Children’s Hospital of Eastern Switzerland, St. Gallen, Switzerland
12
Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland
13
Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
14
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
15
Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
16
Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
✉
Correspondence: L. Flatz, Kantonsspital St. Gallen, Institute of Immunobiology, Rorschacher Strasse 95, 9007 St. Gallen, Switzerland (lukas.flatz@kssg.ch).
Collection date 2021 Nov 1.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC8787408 PMID: 34550333
This corrects the article "Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies", ciaa1496.